List of insiders holdings for Cellectar Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner | 2015-02-03 17:04:49 | 0 2,208,368 | 2,208,368 | Form 4 |
| AWM Investment Company Inc. 10% Owner | 2016-01-11 14:40:48 | 1,066,000 0 | 1,066,000 | Form 13G |
| CARUSO JAMES V President and CEO | 2024-06-18 17:04:27 | 900,000 0 | 900,000 | Form 4 |
| WISCONSIN ALUMNI RESEARCH FOUNDATION 10% Owner | 2016-12-02 13:19:57 | 602,817 0 | 602,817 | Form 13D |
| Longcor Jarrod Chief Operating Officer | 2024-06-18 17:04:49 | 500,000 0 | 500,000 | Form 4 |
| Elefant Dov Chief Financial Officer | 2022-01-27 16:06:06 | 422,000 0 | 422,000 | Form 4 |
| Friend John E. II Chief Medical Officer | 2021-03-05 17:46:09 | 330,000 0 | 330,000 | Form 4 |
| Pedder Simon President and CEO | 2014-08-22 16:38:50 | 290,878 0 | 290,878 | Form 4 |
| Kolean Chad J Chief Financial Officer | 2024-06-18 17:04:06 | 290,000 0 | 290,000 | Form 4 |
| Hertzberg Richard significant owner | 2016-11-01 20:45:15 | 280,000 0 | 280,000 | Form 4 |
| Shustov Andrei Senior Vice President, Medical | 2024-06-18 17:03:28 | 260,000 0 | 260,000 | Form 4 |
| Lea Darrell Shane Chief Commercial Officer | 2024-06-18 17:02:59 | 260,000 0 | 260,000 | Form 4 |
| BERNS PAUL L Director | 2016-04-21 18:01:54 | 234,742 0 | 234,742 | Form 4 |
| Cormorant Asset Management LLC Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner | 2017-02-14 16:17:33 | 106,648 0 | 106,648 | Form 13G |
| Swirsky Douglas J Director | 2024-06-18 17:01:29 | 90,000 0 | 90,000 | Form 4 |
| Grachev Igor D Chief Medical Officer | 2020-01-08 16:02:19 | 80,000 0 | 80,000 | Form 4 |
| Chanan-Khan Asher Director | 2024-06-18 17:00:17 | 60,000 0 | 60,000 | Form 4 |
| DRISCOLL FREDERICK W Director | 2024-06-18 17:00:33 | 60,000 0 | 60,000 | Form 4 |
| NEIS JOHN Director | 2024-06-18 17:00:59 | 60,000 0 | 60,000 | Form 4 |
| Loren Stefan Director | 2024-06-18 17:01:59 | 60,000 0 | 60,000 | Form 4 |
| HILL STEPHEN A Director | 2020-06-25 16:22:59 | 50,000 0 | 50,000 | Form 4 |
| Szakacs Cameron VP of Clinical Development | 2014-12-18 16:06:07 | 50,000 0 | 50,000 | Form 4 |
| Weichert Jamey P Chief Scientific Officer | 2016-05-23 19:42:18 | 42,895 0 | 42,895 | Form 4 |
| POSNER BRIAN M Chief Financial Officer | 2019-01-18 16:17:46 | 30,000 0 | 30,000 | Form 4 |
| McNeil Kathryn M See Remarks | 2014-08-18 10:57:43 | 20,000 0 | 20,000 | Form 3 |
| Genn John Patrick VP of Business Development | 2015-03-04 19:06:15 | 10,000 0 | 10,000 | Form 4 |
| Bernhardt Charles Thomas III Interim CFO | 2019-03-11 16:02:22 | 0 0 | 0 | Form 3 |
| Hamill John P. Interim CFO | 2017-09-08 11:58:26 | 0 0 | 0 | Form 3 |